Browse studies

Find your next paid study

168 recruiting studies matching your filters

Implementing a Proactive Approach to Communicate and Teach About HPV Vaccination in Pharmacies: IMPACT HPV Study

This clinical trial compares usual care to interpersonal communication training and vaccination workflow training, alone or in combination, for improving commu…

Human Papillomavirus-Related Carcinoma

Estimated

~$10 – $6,250

Fred Hutchinson Cancer CenterNCT06926062

Observational

Improving TelePrEP Initiation and Retention Outcomes in the US: The MISTR+ Study

This study uses a rapid randomized controlled trial (RCT) design to examine HIV pre-exposure prophylaxis (PrEP) delivered through telehealth. This study will d…

Human Immunodeficiency Virus

Estimated

~$10 – $6,250

Emory UniversityNCT07821671

Observational

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening (MATCHES)

This innovative Multilevel Action Toward Colorectal Cancer (CRC) and Hepatitis C Virus (HCV) Education and Screening (MATCHES) intervention aims to promote con…

Colorectal Cancer ScreeningHepatitis C Virus

Estimated

~$10 – $6,250

H. Lee Moffitt Cancer Center and Research InstituteNCT06745895

Phase 4

Comparison of the Immune Response After Administration of 2 vs. 3 Doses of the FDA-approved 9-Valent HPV Vaccine Among Women 27-45 Years of Age

The goal of this clinical trial is to compare a 2-dose and 3-dose series of 9vHPV vaccine among 27-45-year-old females to assess if 2 doses elicit a noninferio…

ImmunizationHPV InfectionHuman Papillomavirus

Estimated

~$10 – $6,250

The University of Texas Medical Branch, GalvestonNCT05672927

Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma

The purpose of this study is to better understand the natural history of oropharyngeal carcinoma (OPC), with or without an association with the human papilloma…

Oropharyngeal CarcinomaHuman Papilloma Virus

Estimated

~$10 – $750

Stanford UniversityNCT05880797

Observational

Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial

Human papillomavirus (HPV) vaccines have potential to prevent an average of 26,900 cancer cases each year in the United States, but vaccine coverage rates rema…

Human Papillomavirus (HPV) Vaccines

Estimated

~$10 – $6,250

University of FloridaNCT03429413

Phase 2

Omission of Immediate Postoperative Radiation in Patients With Intermediate Pathological Risk Features and Negative Two-Week Post-Operative ctHPVDNA (OPERATION Trial)

This single-arm Phase II trial evaluates whether omission of postoperative radiotherapy is feasible and oncologically safe in select patients with HPV-associat…

Squamous Cell CarcinomaHuman Papilloma Virus (HPV)Oropharyngeal Squamous Cell Carcinoma (OPSCC)

Estimated

~$10 – $6,250

Medical University of South CarolinaNCT07513389

Phase 1

A Phase 1, Open-label, Single-arm Study to Evaluate the Pharmacokinetics and Safety of Letermovir in Pediatric Kidney Transplant (KT) Recipients Less Than 18 Years of Age and Weighing Less Than 40 Kilograms

Researchers are looking for a way to prevent cytomegalovirus (CMV) in children and adolescents who receive a kidney transplant (KT) and weigh less than 40 kilo…

Cytomegalovirus Prophylaxis

Estimated

~$10 – $8,750

Merck Sharp & Dohme LLCNCT07199465

Phase 3

An Open-Label Prospective Randomized Trial of Family Donor-Derived ADV or CMV CTLs Plus Standard of Care (SOC) vs SOC Alone in Children, Adolescents and Young Adults Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) With Refractory ADV or CMV Infection/Viremia

Patients with refractory ADV or CMV infection post allogeneic stem cell transplant will be randomized to either Family donor-derived viral specific cytotoxic T…

CMVAdV InfectionAdV Reactivation+2 more

Estimated

~$10 – $6,250

New York Medical CollegeNCT07225972

Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies

Background: Respiratory viruses circulate throughout the year and around the globe. Wearable and sensor devices, like smartwatches, may be able to help monito…

InfluenzaRespiratory VirusCoronavirus

Estimated

~$10 – $675

National Institute of Allergy and Infectious Diseases (NIAID)NCT04772170

Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health

Background: People who get COVID-19 have a wide range of symptoms. They also recover from COVID-19 in different ways. In this study, researchers will use surv…

Post-Coronavirus Disease 19

Estimated

~$10 – $675

National Institute of Neurological Disorders and Stroke (NINDS)NCT04573062

Phase 1

A Dose Escalation Phase I Trial of the Safety and Immunogenicity of RG1-VLP, A Candidate Broadly Protective Vaccine for the Prevention of HPV-Associated Cancer

This phase I trial tests the safety, side effects, and best dose of RG1-virus-like particle (VLP) in preventing human papillomavirus (HPV)-related cancers in w…

Human Papillomavirus-Related Carcinoma

Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT05985681